miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma-Reference-Cited by-同舟云学术

miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma

Published:2014-03-16 Issue:9 Volume:5 Page:2513-2528
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Minna Emanuela¹,Romeo Paola¹,De Cecco Loris²,Dugo Matteo²,Cassinelli Giuliana³,Pilotti Silvana⁴,Degl’Innocenti Debora¹,Lanzi Cinzia³,Casalini Patrizia⁵,Pierotti Marco A.⁶,Greco Angela¹,Borrello Maria Grazia¹

Affiliation:

1. Molecular Mechanisms Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

2. Functional Genomics Core Facility, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

3. Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

4. Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

5. Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

6. Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on the expression of Mir-218-2 in the serum of patients with papillary thyroid cancer and its clinical significance;European Journal of Translational Myology;2024-08-29

2. Polyphenol galangin induces the ROS and ER stress-mediated intrinsic and extrinsic apoptotic pathways towards human colon carcinoma HCT-116 cells;Emirates Journal of Food and Agriculture;2023-12-28

3. Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review;Non-coding RNA Research;2023-09

4. Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression;Epigenetics;2023-05-11

5. The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer;Cancers;2022-07-07